Data / Form D filings / Prelude Therapeutics Inc
Prelude Therapeutics Inc: Form D filings
Prelude Therapeutics Inc, a biotechnology company in Wilmington, DE, filed 5 Form D notices with the SEC between 2016 and 2020. The latest, on August 28, 2020, reports $50 million sold of a $50 million offering to 7 investors.
Find out what Prelude Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 Powder Mill Road, Experimental Station E400/3213, Wilmington, DE, 19803
- Phone
- (302) 547-3768
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1678660
The full lists. Form D filings in Delaware: 1,342 rows, $67.10, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2020 | New notice | $49,999,969 | $49,999,969 | $0 | 7 | Aug 21, 2020 | sec.gov |
| Jun 17, 2019 | New notice | $59,999,998 | $29,999,999 | $29,999,999 | 6 | May 31, 2019 | sec.gov |
| Aug 17, 2018 | Amendment | $29,999,998 | $29,999,998 | $0 | 7 | Oct 6, 2017 | sec.gov |
| Oct 20, 2017 | New notice | $12,000,000 | $12,000,000 | $0 | 7 | Oct 6, 2017 | sec.gov |
| Jul 11, 2016 | New notice | $5,000,000 | $5,000,000 | $0 | 8 | Jun 27, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Bonita | Director | |
| Victor Sandor | Director | |
| Peggy C. Scherle | Executive Officer | |
| Christopher C. Pierce | Executive Officer | |
| Deborah C. Morosini | Executive Officer | |
| Krishna Vaddi | Executive Officer, Director | |
| Brian C. Piper | Executive Officer | |
| Mardi C. Dier | Director | |
| Paul Friedman | Director | |
| Kelvin Neu | Director | |
| David C. Mauro | Executive Officer | |
| Andrew C. Combs | Executive Officer |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Aug 24, 2020 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Prelude Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.